Table 3 Baseline characteristics

Demographics

Sex

Age

Ethnicity

Medical history

COVID-19 history and management

Intended for hospital or for community management

Co-morbidities

Chronic kidney disease

Hypertension

Diabetes

Cardiovascular disease (including heart failure, ischemic heart disease, acute myocardial infarction, congenital heart disease, stroke, peripheral vascular disease)

Cancer in last 5 years (not including basal cell carcinoma and squamous cell carcinoma)

Chronic respiratory illness

Severe liver disease (Child-Pugh-Turcotte score 10–15 or biliary obstruction)

Other relevant medical conditions

Pregnancy status (pregnant or breastfeeding)

Medications

Renin-angiotensin-aldosterone system (RAAS) inhibitor (including ACEi, ARB, aldosterone antagonist, angiotensin receptor-neprilysin inhibitor, Aliskiren)

Non-RAAS inhibitor blood pressure (BP)-lowering agent

Glucose-lowering medication

Steroids

Steroid inhalers/nasal spray

COVID-19-specific therapies

Other immunosuppressants

Other inhalers

Vasopressor

Proton-pump inhibitor (e.g. omeprazole, esomeprazole, pantoprazole)

Aspirin

Lipid-lowering agent (e.g. statins, fibrates)

Antimicrobials

Other

Smoking status

Current, previous, non-smoker

Physical examination

Blood pressure (mmHg)

Height (cm)

Weight (kg)

Body mass index (kg/m²)

Laboratory measures

Serum creatinine (mg/dL)

Estimated glomerular filtration rate (mL/min/1.73 m²)

White cell count (x 10⁹/L)

Neutrophils and lymphocytes (x 10⁹/L)

D-Dimer (mg/L FEU or mg/L DDU)

C-reactive protein (mg/L or nmol/L)

Creatine kinase (U/L)